These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 2473117)

  • 1. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
    Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.
    Winter CC; Carreno BM; Turner RV; Koenig S; Biddison WE
    J Immunol; 1991 May; 146(10):3508-12. PubMed ID: 2026879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of peptide binding by the HLA-A2.1 molecule.
    Shimojo N; Maloy WL; Anderson RW; Biddison WE; Coligan JE
    J Immunol; 1989 Nov; 143(9):2939-47. PubMed ID: 2553813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule.
    Hogan KT; Clayberger C; Le AX; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Dec; 141(11):4005-11. PubMed ID: 2460555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.
    Jelachich ML; Cowan EP; Turner RV; Coligan JE; Biddison WE
    J Immunol; 1988 Aug; 141(4):1108-13. PubMed ID: 2456340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic activity and lymphokine production of T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ cytotoxic T lymphocyte (CTL) clones recognizing HLA-A2 and HLA-A2 mutants. Recognition of TCR-gamma delta+ CTL clones is affected by mutations at positions 152 and 156.
    Spits H; Paliard X; Engelhard VH; de Vries JE
    J Immunol; 1990 Jun; 144(11):4156-62. PubMed ID: 2111341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.
    Hogan KT; Shimojo N; Walk SF; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Exp Med; 1988 Aug; 168(2):725-36. PubMed ID: 3261776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
    Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
    Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules.
    Hengel H; Burke K; Kyburz D; Zinkernagel RM; Koszinowski UH
    J Immunol; 1995 May; 154(9):4557-64. PubMed ID: 7722309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.
    Morrison J; Elvin J; Latron F; Gotch F; Moots R; Strominger JL; McMichael A
    Eur J Immunol; 1992 Apr; 22(4):903-7. PubMed ID: 1372560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
    Bodmer H; Ogg G; Gotch F; McMichael A
    Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
    Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
    J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.
    Newberg MH; Ridge JP; Vining DR; Salter RD; Engelhard VH
    J Immunol; 1992 Jul; 149(1):136-42. PubMed ID: 1607650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove.
    Shimojo N; Anderson RW; Mattson DH; Turner RV; Coligan JE; Biddison WE
    Int Immunol; 1990; 2(3):193-200. PubMed ID: 2088485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
    Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
    J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
    Engelhard VH; Lacy E; Ridge JP
    J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.